Tuberculosis experts pin hopes of controlling disease on 12 vaccines in development

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e6981 (Published 16 October 2012)
Cite this as: BMJ 2012;345:e6981

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Geoff Watts
  1. 1London

The advent of more effective vaccines against tuberculosis is an increasingly realistic possibility, say public health experts with an interest in the illness. Tuberculosis is currently the world’s second deadliest infection, with 8.8 million new cases in 2010.

“In the last decade we’ve gone from having no vaccines in development to now having 12 different candidates at various stages in the clinic and in human trials,” said Ann Ginsberg, vice president of scientific affairs for Aeras, a foundation devoted to the development of vaccines against tuberculosis.

Increasingly concerned over the rise of drug resistant tuberculosis, she and others in the field have long insisted that …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL